Q2 Overall gross margin improved 187 bps to 20.9% and operating margin declined 168 bps to 4.8%.
Inventories were at $17.1M (-3.4% Y/Y).
Backlog was $101M (-14.4% Y/Y), the Company has a strong volume of outstanding quotations globally and expects to be awarded significant projects over the balance of the fiscal year.
Company has cash and equivalents of $9.5M (-19.5% Y/Y) & Working capital was $36.4M (+6.4% Y/Y).
Company's debt-to-equity ratio at Oct 31, 2018 was .14-to-1, as compared to .24-to-1 a year ago.
Previously: Kewaunee Scientific misses on revenue (Dec. 04 2018)
Subscribe for full text news in your inbox